Crossmark Large Cap Growth ETF (CLCG)

Currency in USD
27.00
0.00(0.00%)
Closed·
27.00-0.02(-0.06%)
·
Unusual trading volume
Day's Range
26.8827.02
52 wk Range
23.5028.18

Key Statistics

Morning Star Rating
-
Risk Rating
-
Bid / Ask
-
Prev. Close
27.00
Price Open
26.88
Volume
18,341
Average Vol. (3m)
3,776
1-Year Change
-
Day’s Range
26.88-27.02
52-Week Range
23.50-28.18
Market Cap
823.23B
Expense Ratio
0.50%
How do you feel today about CLCG?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 1000904904----
Fund Return-9.62%-9.62%----
Rank in Category609609----
Percentile Rank6060----
NVDA14.91%198.35-0.26%19,271
AAPL13.03%263.40-1.14%12,299
GOOGL8.84%336.02-0.33%6,726
MSFT7.68%420.13+2.17%4,888
AVGO7.44%398.36+0.41%4,794
V3.33%315.10-0.26%2,632
MA3.13%518.54-0.27%1,504
ANET2.97%161.01+4.33%4,771
AMZN2.49%249.70+0.48%2,534

Popular Inc

-2.37%--3,955

Crossmark ETF Trust - Crossmark Large Cap Growth ETF is an exchange traded fund launched and managed by Crossmark Global Investments, Inc. It invests in public equity markets. The fund invests in stocks of companies operating across diversified sectors. The fund invests in growth stocks of large-cap companies, within the market capitalization range of the Russell 1000 Growth Index. It invests in stocks of companies that are deemed socially conscious in their business dealings. The fund employs fundamental and quantitative analysis to create its portfolio. The fund does not invest in stocks of companies operating across production, distribution, retail, supply or licensing of alcohol or related products, tobacco or related products, gambling, abortions and/or the production of drugs that are used to terminate pregnancy, leasing real estate to facilities providing abortions, scientific research using stem cells derived from human embryos, fetal tissue or human embryo cloning techniques, production of adult entertainment or materially involved in the distribution or retail of adult entertainment, production, distribution, retail, supply or licensing of psychoactive recreational cannabis or derivative products sectors. The fund employs external research to create its portfolio. Crossmark ETF Trust - Crossmark Large Cap Growth ETF was formed on July 23, 2025 and is domiciled in the United States.

Industry
-
Sector
-
Equity Type
ETF

FAQ

How is the performance of CLCG?

As of Apr 16, 2026, CLCG is trading at a price of 27.00, with a previous close of 27.00. The stock has fluctuated within a day range of 26.88 to 27.02, while its 52-week range spans from 23.50 to 28.18.

What is the current price of CLCG?

The CLCG stock price today is 27.00.

Does CLCG Pay Dividends? What’s The Current Dividend Yield?

The Crossmark Large Cap Growth dividend yield is 0.07%.

What is the CLCG expense ratio?

The expense ratio for CLCG is 0.50%.

What is the CLCG premarket price?

CLCG's last pre-market stock price is 27.00.

What is the CLCG after hours price?

CLCG's last after hours stock price is 27.00.

What is the P/E ratio of CLCG?

The P/E ratio for CLCG is 21.72.

What is CLCG?

CLCG is an ETF issued by Crossmark Inc and is listed and traded on the New York Stock Exchange.

From a Technical Analysis Perspective, Is CLCG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What is the CLCG market cap?

The market cap for CLCG is 25.92M.

When is the CLCG dividend date?

The next dividend date for CLCG is Dec 18, 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.